Pacific Biosciences Of California (PACB)
$2.60 -10.17% Close Oct 30, 2026 Live
Pacific Biosciences Of California stock today
Pacific Biosciences Of California closed at $2.60 on October 30, 2026, down 10.17% on the day. Over the past year it returned +34.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $809 million.
$1.00$2.00$3.00
NovJan 2026MarMayJulSep
| Period | PACB | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.9% | -0.9% |
| 3 months | +76.0% | +2.1% |
| Year to date | +39.3% | +11.7% |
| 1 year | +34.3% | +12.4% |
| 3 years | -63.4% | +88.5% |
| 5 years | -90.2% | +76.0% |
Key statistics
- Market value
- $809M
- Price / sales
- 5.1
- 52-week range
- $1.11 to $2.90
- Next report
- Nov 4, 2026
About Pacific Biosciences Of California
Develops and manufactures DNA sequencing instruments and consumables for genomic research and diagnostics.
Sector: Health Care
More on Pacific Biosciences Of California
- Financials: revenue, earnings and segmentsRevenue +4% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $305.75 today
No forecast, no recommendation. This page describes Pacific Biosciences Of California from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.